黑色素瘤和免疫细胞中的PPAR-γ:对疾病发病和治疗影响的洞察
Vladimir Sobolev1, Ekaterina Tchepourina1, Anna Soboleva1
1Laboratory of Physicochemical and Genetic Problems in Dermatology, Center for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow 109029, Russia.
Cells
|April 11, 2025
概括
过氧体增殖器激活受体玛 (PPAR-γ) 通过调节细胞生长和新陈代谢,显示出对黑色素瘤的保护作用. 需要进一步的研究来理解其复杂的作用,并解决针对性治疗的安全问题.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤色素变化,包括和黑色素瘤,影响外观和社会福祉.
- 恶性黑色素瘤是一种具有高转移潜力的侵袭性皮肤癌,特别是在年轻人中.
- 过氧体增殖器激活受体玛 (PPAR-γ) 和其连接体已经证明对黑色素瘤有保护作用.
研究的目的:
- 审查目前对PPAR-γ在黑色素瘤发育和进展中的作用的理解.
- 总结PPAR-γ的已知生物效应及其在黑色素瘤瘤发生中的参与.
- 突出PPAR-γ激动剂在黑色素瘤治疗中的潜力,并确定未来研究的领域.
主要方法:
- 关于PPAR-γ及其在黑色素瘤中的参与的已发表数据的文献综述.
- 分析PPAR-γ作为细胞过程中的转录因子的功能.
- 检查PPAR-γ在瘤发生过程中的细胞增殖,细胞亡,新陈代谢和免疫性中的调节作用.
主要成果:
- PPAR-γ调节黑色素瘤中的关键细胞过程,包括增殖,分化,亡和生存.
- 在黑色素瘤发育过程中,PPAR-γ 影响了代谢变化和 stromal 细胞的免疫性.
- PPAR-γ激动剂在黑色素瘤治疗中显示出向缺氧诱导血管生成的潜力,具有取决于背景的效果.
结论:
- PPAR-γ在黑色素瘤中发挥着重要,多方面的作用,影响瘤生长,新陈代谢和免疫相互作用.
- 针对PPAR-γ的药物可能在特定患者群体中有效,但需要进一步研究.
- 需要进行额外的研究,以阐明PPAR-γ的鲜为人知的生物效应,并解决临床应用的安全问题.
相关概念视频
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:31The Intrinsic Apoptotic Pathway
5.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K